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1. Introduction 
Ochratoxins are secondary metabolic products of different Aspergillus and 
Penicillium species. Based on their chemical structure we can distinguish 
Ochratoxin A, B and C toxins; Ochratoxin A (OTA) is highly the most 
toxic derivative. OTA is built up from a dihydroisocoumarin moiety linked 
with L-phenylalanine. OTA occurs mainly in the Balkan region, however, it 
is present world-wide in detectable amounts in cereals, fruits, bakery-, 
meat- and dairy products, wine, beer, coffee and even in eggs.  Because of 
its wide occurrence and high thermal stability, its eradication from the food 
chain with the currently known methods seems to be impossible.  
Since OTA is a food contaminant, it enters orally to the human organism; it 
has a high oral bioavailability (about 93% in humans). After the toxin 
reaches the bloodstream more than 99% of OTA binds to serum proteins 
(mainly to albumin), resulting in its very long plasma half-life (about 1 
month).  OTA binds to human serum albumin (HSA) in dianionic form; its 
main binding site is located at subdomain IIA. Some animal experiments 
suggest that displacement of OTA from albumin speeds up its elimination 
and prevents the accumulation of the toxin in target tissues. OTA is 
excreted mainly by urine. 
OTA is primarily a nephrotoxic mycotoxin, however, several other adverse 
effects of OTA are also suggested. In recent years, numerous in vitro and in 
vivo studies have been performed in order to explore its exact mechanism 
of action. Based on these results many theories are known, on the other 
hand we still lack strong evidences.  The suspected mechanisms are 
inhibition of protein synthesis and cellular energy production, DNA adduct 
formation, induction of oxidative/nitrosative stress, disruption of calcium 
homeostasis, provocation of apoptotic cell death and cell cycle arrest. At 
present there are no proven effective antidote or prevention strategies 
against OTA toxicity.  
In the human organism OTA is able to interact with several molecules, e.g. 
ions, different peptides and proteins. One of the most important interactions 
is the complex formation with HSA because it plays a key role in the 
toxicokinetics of OTA. Further investigation of molecular interactions of 
OTA is reasonable and necessary for the deeper understanding of its 
mechanism of action and for developing potential prevention strategies.  
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2. Aims 
Although, many theories have been published, the exact mechanism of 
action of OTA is currently unclear. We do not know which effect plays a 
key role in the mechanism of action of OTA during the long term human 
exposure of the toxin. In order to alleviate OTA-mediated negative impacts, 
the deeper understanding of its biochemical behavior is necessary. For this 
purpose our main goals were the followings: 
 
 Investigation the physico-chemical behavior of OTA: Study of its 
interactions with ions, proteins and other endogenous molecules. 
 
 Quantitative analysis of OTA-albumin interaction, identification of 
potential competitor molecules with low toxicity. 
 
 Identification of agents which are suitable to decrease the absorption or 
to enhance the elimination of OTA. 
 
 Investigation of in vitro toxic effects of OTA in cell cultures. 
 
 Identification of agents which counteract with the toxicodynamic 
effects of OTA. 
 
3. Methods 
Hitachi F4500 fluorimeter and Fluorolog τ3 spectrofluorimetric system 
(Jobin-Yvon/SPEX) were used for fluorescence spectroscopic and 
fluorescence polarization measurements, experiments were performed at 
+25 °C (with the exception of thermodynamic studies) in the presence of 
air. 
For quantitative determination of OTA and OTA
2-
-Mg
2+
 complex with 
chromatography, integrated high performance liquid chromatography 
(HPLC) system (Agilent 1100) was applied, it was equipped with a 
quaternary pump, a degasser, an autosampler, an injector with a 100-μl 
sample loop, a column oven and a fluorescent detector. Data were recorded 
and evaluated using Agilent ChemStation (Rev.B.03.02-SR2) software. 
Separation was performed on a LiChroCART
®
 4 mm × 125 mm, 5-µm 
particle size, Merck Purospher STAR
®
 RP-18e (endcapped) column with a 
guard cartridge (TR-C-160-K1; ABLE&E-Jasco) using binary gradient 
mobile phase. 
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A Berthold Lumat LB9507 luminometer was applied to quantify ATP 
concentrations. Flow cytometry measurements were performed on a 
Beckman-Coulter FC500 flow cytometer, data analysis was done using 
CXP software. Promega GloMax
®
-Multi Microplate Multimode Reader 
was used for ROS-measurements. 
MDCK (tubular kidney, immortalized, ATCC: CCL 34) adhering cells 
were cultured in DMEM (high glucose, 4.5 g/l) with 10% FBS plus 
penicillin (100 U/ml) and streptomycin (100 µg/ml) in 25 cm
2
 sterile plastic 
flasks (VWR) and in 96-well sterile plastic plates (VWR), furthermore, 6-
well sterile plastic plates (VWR) were applied for flow cytometric analyses. 
Cells were kept at 37 °C in the presence of 5% CO2 in humidified 
atmosphere. All sterile work was carried out in an Aireguard-126300 
(Nuaire) vertical laminar box. 
Total protein, ATP and ROS concentrations were determined using 
fluorescamine, luciferin-luciferase and C400 reagents, respectively. 
Viability of control and treated cells was evaluated applying calcein and 
propidium iodide – FITC-AnnexinV viability assays. For cell cycle 
analysis, after permeabilization cells were labeled with propidium iodide.  
All experiments were repeated at least three times. Statistical analyses were 
performed with One-Way ANOVA using IBM SPSS Statistics software 
(Version 20). P < 0.05 was set as the level of significance. 
 
4. Results and discussion          
4.1. Interaction of Ochratoxin A with serum albumin. Fluorescence 
characteristics of OTA are highly influenced by the microenvironment. 
Depending on the pH, OTA could be present in nonionic, monoanionic 
(OTA
-
) and dianionic (OTA
2-
) forms. Under physiological conditions 
dianionic OTA predominates because pH 7.4 is higher than pKa values of 
OTA, furthermore, the high concentration of alkali earth ions also shift the 
equilibrium toward the formation of OTA
2-
.  
Nonionic and monoanionic OTA show the same spectra (λexc = 332 nm, λem 
= 451 nm). On the other hand, fluorescence excitation and emission 
wavelength maxima of OTA
2-
 are different from the two other forms (λexc = 
380 nm, λem = 443 nm) and it represents a much higher fluorescence signal. 
Interaction of OTA with albumin results in spectral changes in its 
fluorescence: the excitation and emission wavelength maxima of OTA
2-
-
HSA complex are 393 and 446 nm, respectively. Furthermore, the 
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fluorescence intensity of OTA
2-
-HSA complex is considerably higher than 
that of OTA
2-
 in the same concentration.     
Since the complex formation of OTA with albumin plays a key role in the 
toxicokinetics of OTA, it is one of the main subjects of our interest. 
Complex stability of OTA-HSA was determined applying three different 
experimentations (fluorescence intensity, polarization and quenching) and 
in all cases association constants (K) were higher than 10
7
 dm
3
/mol. This 
value is very high compared to other albumin-ligand complexes and it 
explains the extremely long plasma half-life of OTA. 
The binding affinities of OTA with different albumin species show major 
differences. Association constants of OTA-albumin complexes were 
quantified with human (HSA), bovine (BSA) and rat serum albumin (RSA) 
in PBS buffer (pH 7.4) at 25 °C. The determined values are the following: 
logKOTA-HSA = 7.65 ± 0.36, logKOTA-BSA = 6.48 ± 0.22 and logKOTA-RSA = 
6.17 ± 0.12. Our results demonstrate that 15-fold and 30-fold higher 
complex stabilities were observed in the case of OTA-HSA complex 
compared to OTA-BSA and OTA-RSA complexes, respectively. 
Thereafter, a previously published fluorescence polarization-based method 
was compared to two intensity-based approaches to verify its suitability for 
quantitative investigation of OTA-HSA interaction. The results of the three 
applications show very similar data, indicating that we are able to follow 
precisely and quantitatively the complex formation of OTA with HSA. To 
investigate competitive interactions of OTA with different drugs and 
flavonoids for binding to HSA, the fluorescence polarization model was 
applied subsequently. 
4.2. Competitive interaction of drugs with OTA for binding to HSA. In 
this part of the studies our aim was to identify further drug molecules 
which are able to displace OTA from the surface of HSA. 13 different 
drugs were examined using 1.0 µM OTA, 1.7 µM HSA and 40, 70 and 100 
µM drug concentration. Experiments were performed in PBS buffer (pH = 
7.4) at 25 °C. Acetylsalicylic acid, nifedipine, phenobarbital, phenytoin, 
theophylline and verapamil did not show any interaction with the OTA-
HSA complex. In contrast, ibuprofen, indometacin, furosemide, glipizide, 
phenylbutazone, simvastatin and warfarin proved to be as effective 
competitors. The most conspicuous effect was represented by indometacin 
and phenylbutazone. In competing efficiency these two drugs were 
followed by warfarin, furosemide and ibuprofen (in this order). Finally, 
glipizide and simvastatin can be mentioned with a lower but measurable 
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effect. The competitive interaction of some NSAIDs (piroxicam, 
indometacin) and warfarin with OTA had already been reported in previous 
studies. On the other hand, the identification of furosemide, glipizide and 
simvastatin as effective competitors, furthermore, the absence of 
displacement in the case of acetylsalicylic acid and phenobarbital (in 
contrast with previous assumptions) are new observations. We suggest that 
this explorative investigation will be useful in the future to examine the 
effect of these drugs on OTA toxicity in humans using epidemiologic 
approaches. 
4.3. Competitive interaction of flavonoids with OTA for binding to 
HSA. Recent studies highlighted that dietary flavonoids bind to serum 
albumin with high affinity, occupying the same binding site (Sudlow’s site 
I) than OTA. Furthermore, toxicity of flavonoids is low thus we can apply 
them in higher amounts without known side effects. Therefore, this 
molecular group seems to be suitable for the displacement of OTA from 
HSA and using this principle the elimination of OTA from the human 
organism can be enhanced. In our experiment, 12 different flavonoid 
aglycones were tested using the same conditions described in the previous 
section (4.2.) with the exception of the applied flavonoid concentrations 
(10, 25 and 50 µM, respectively). Comparing the effectiveness of 
flavonoids belonging to various subclasses, we found that the tested 
flavones and flavonols possess the ability to remove OTA from its albumin 
complex, while flavanones and isoflavonoids showed negligible or no 
displacing properties. These findings suggest that the presence of a C2-C3 
double bond in ring C in conjugation with 4-carbonyl group (as in flavones 
and flavonols) might be critical for the binding affinity. Although, daidzen 
possesses these important structural features, it was an ineffective 
competitor. This could be due to the fact that the phenyl group in the 
isoflavonoid structure is substituted at the C3 position of the dihydropyrane 
ring instead of regular C2 position. Interpreting the data for all three 
flavonoid concentrations in the competition experiments, galangin showed 
far the highest effect followed by quercetin. They both belong to flavonols 
possessing C3 hydroxyl group which also seems to have an important role. 
The comparison of obtained results for all tested flavonols showed that the 
presence of hydroxyl groups in the ring B obviously reduces their 
competing abilities. Moreover, their properties also depend on the number 
and position of the substituents. For example quercetin with the C2’,C3’-
dihydroxy structures in the ring B was a better competitor than morin with 
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C1’,C3’-hydroxyl groups as well as myricetin which has three hydroxyl 
groups (C2’,C3’,C4’) in the B ring. While the C3-hydroxyl group in ring C 
causes higher binding strength, it is possible that the ortho-hydroxyl group 
(position C1’) of morin and the two meta-hydroxyl groups (positions C2’ 
and C4’) of myricetin can reduce the binding affinity because of steric 
reasons. Although, a few animal studies suggest the positive effect of 
displacement of OTA from its albumin-bound form, we still lack strong 
evidences on its beneficial action. Therefore, it is feasible to postulate that 
the increased concentration of free OTA results in its increased metabolism 
but besides the detoxification in the body (e.g. formation of 4-hydroxy-
OTA or 10-hydroxy-OTA metabolites) the formation of potential toxic or 
reactive metabolites cannot be excluded.  However, at present we do not 
know any research that identifies the negative impact of this type of 
interaction.  
4.4. Interaction of OTA with alkali and alkaline earth ions. In this part 
of the studies 0.1 M TRIS-HCl buffer (pH 7.4) was applied. Experiments 
were performed using the chloride salts of Li
+
, Na
+
, K
+
, Mg
2+
, Ca
2+
 and 
Ba
2+
 ions. In the presence of alkali earth ions (Li
+
, Na
+
 and K
+
) the 
fluorescence wavelength maxima of OTA did not change but alkali earth 
ions shifted the chemical equilibrium towards the formation of its dianionic 
form; the order of its magnitude was Li
+
 > Na
+
 ~ K
+
. In contrast, the 
presence of alkaline earth metal ions caused the shifting of both the 
excitation and emission wavelength maxima of OTA (Mg
2+
: λexc = 375 nm, 
λem = 427 nm; Ca
2+
: λexc = 375 nm, λem = 433 nm; Ba
2+
: λexc = 377 nm, λem = 
439 nm) and a significant increase of its fluorescence intensities was also 
observed. Our investigations highlighted that OTA
2-
 is highly the more 
preferred form for complex formation.  
Thereafter, stability constants of OTA-cation complexes were quantified 
using Hyperquard2006 program package (Protonic Software). The 
determined logK values were the followings: OTA
2-
-Mg
2+ 
= 3.40 ± 0.01, 
OTA
2-
-Ca
2+
 = 2.78 ± 0.01, OTA
2-
-Ba
2+
 = 1.92 ± 0.02. These data 
demonstrate that the stability of OTA
2-
-Mg
2+
 complex is 4-fold higher than 
OTA
2-
-Ca
2+
 and 30-fold higher than OTA
2-
-Ba
2+
. Thermodynamic studies 
(performed by using the van’t Hoff theory) suggest that complex formation 
of OTA with cations is an entropy-driven process because the desolvation 
of alkaline earth ions results in entropy production. The investigation of 
OTA
2-
-Mg
2+
 interaction in PBS buffer (pH 7.4) showed that 15,000-fold 
higher Mg
2+
 concentration is needed than OTA to achieve the complete 
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saturation of OTA with magnesium ion. Based on this observation, we 
suggest that the protein-free fraction of OTA is partially presented as 
magnesium complex in body fluids.  
4.5. Application of OTA
2-
-Mg
2+
 complex formation for HPLC-FLD 
system. Since the OTA
2-
-Mg
2+ 
complex is relatively stable and because of 
the complex formation of OTA
2-
 with Mg
2+
 results in the significant 
elevation of its fluorescence, we hypothesized that the interaction maybe 
suitable for developing more sensitive fluorescence analytical methods, e.g. 
in the case of chromatographic analyses. We tested this idea on HPLC-FLD 
instrument. The applied alkaline mobile phase [Triethylamine buffer 
(triethylamine hydrochloride/triethylamine 5 mM, pH 9.8) – acetonitrile; 
the gradient elution was as follows: from 0 to 10 min, acetonitrile was 
increased from 17.5% (v/v) to 25%, while triethylamine buffer was 
decreased from 82.5% to 75%. From 10 to 12 min, acetonitrile and buffer 
returned to the initial values.] was supplemented with Mg
2+
 (its buffer 
component contained 5 mM MgCl2). Because of this slight modification of 
the eluent, the sensitivity of the chromatographic method doubled. So we 
can significantly increase the sensitivity without the considerable elevation 
of costs. In addition, the sample preparation is not affected by the 
application of Mg
2+
 in the mobile phase.   
4.6. Interaction of OTA with zinc ions. Besides alkali and alkaline earth 
ions other cations were also investigated. Our results showed that Zn
2+
 ions 
are able to form complex with OTA. Similarly to OTA
2-
-Mg
2+
 interaction, a 
shift of excitation and emission wavelength maxima (λexc = 370 nm, λem = 
431 nm), an elevation of fluorescence signal and a preference towards 
dianionic OTA were observed. logK = 3.78 (± 0.02) was determined for 
OTA
2-
-Zn
2+
 complex as stability constant in 0.1 M TRIS-HCl buffer (pH 
7.4) at 25 °C. This logK value suggests about 2.5-fold higher stability than 
that was observed for OTA
2-
-Mg
2+
 complex. Since recent in vitro studies 
showed that adverse effects of OTA can be alleviated by zinc 
supplementation, it is possible that OTA
2-
-Zn
2+
 complex formation has a 
biological role.   
4.7. Interaction of OTA with cyclodextrins. The interactions of OTA 
with β- and γ-cyclodextrins were reported in recent publications. On the 
other hand, the stability of OTA-cyclodextrin complexes is low and several 
times complex formation with cyclodextrins does not result in fluorescence 
changes on the spectra of OTA. We tested different chemically modified β-
cyclodextrins (β-CD) to find a derivative which is able to form more stable 
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complex with OTA than previously published OTA-CD complexes. In 
addition, the higher affinity of the CD toward dianionic OTA was a further 
objective. Both requirements were fulfilled by QABCD ([2-hydroxy-3-
N,N,N-trimethylamino]-propyl-β-cyclodextrin-chloride). Unfortunately, the 
inclusion of OTA by QABCD did not result in the changes of its 
fluorescence. On the other hand, cyclodextrins are large enough to decrease 
significantly the rotational freedom of OTA, therefore, the interaction can 
be followed by fluorescence polarization technique. Based on our 
calculations, the stability of OTA
2-
-QABCD complex is 200-fold higher 
than determined for OTA
2-
-β-CD complex. The increase of complex 
stability originates from the ionic interaction which stabilizes the OTA
2-
-
QABCD complex. Furthermore, QABCD forms 130-fold more stable 
complex with dianionic than monoanionic OTA. In addition, the logK value 
was determined for OTA
2-
-QABCD complex (4.46 ± 0.09) suggests 10-fold 
higher complex stability compared to the most stable OTA-CD complex 
described in the literature. The appropriate chemical modification of 
cyclodextrins most probably will allow us to decrease the absorption of 
OTA from the intestinal tract or even to increase its elimination from the 
human organism.             
4.8. Effects of OTA on MDCK cells. After the 24-hour treatment of 
MDCK cells with 0-15 µM OTA, different cellular parameters were 
determined. Cellular total protein and ATP concentrations and the 
fluorescence of calcein significantly decreased in OTA-exposed samples. 
Fluorescence intensity of calcein showed linear correlation with the number 
of living cells (counted with a Bürker-type counting chamber). Based on 
our experiments, the changes in total protein levels show very similar 
characteristics to the decrease in the number on living cells. These 
observations suggest that in our experimental model the inhibition of 
protein synthesis by OTA is not dominant. In contrast, significant decrease 
of ATP/protein ratio and elevation of ROS/protein level were determined. 
Propidium iodide – FITC-AnnexinV viability assay highlights that the 
treatment with OTA results in the elevated number of apoptotic and/or 
necrotic cells, however, only extremely high OTA concentrations cause 
considerable effect. On the other hand, even 5 µM OTA has influence on 
the cell cycle: concentration dependent G2/M phase cell cycle arrest was 
observed, while the number of G0/G1 phase cells decreased and number of 
S phase cells did not change.         
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4.9. Effects of diosmetin on OTA-exposed cells. Numerous substances 
were tested during our experiments to develop an agent which is suitable to 
alleviate the toxic effects of OTA on MDCK cells. When the flavonoid 
aglycone diosmetin (DIOS) was tested, an unexpected phenomenon was 
observed. 6-12-hour treatment with 5-15 µM DIOS resulted in the 
significant elevation of ATP concentrations in MDCK cells and after 24 
hour ATP levels returned to the control level. Calcein viability assay and 
total protein levels did not show any negative effect of DIOS on living cells 
compared to that of control. To understand the mechanism of action of 
DIOS different enzyme inhibitors were applied: sodium fluoride (glycolysis 
inhibitor), 3-bromopyruvate (glycolysis and pyruvate dehydrogenase 
inhibitor) and oligomycin A (ATP synthase inhibitor). Interestingly, 
sodium fluoride and 3-bromopyruvate did not decrease the impact of DIOS 
on ATP levels. In contrast, oligomycin A completely abolished it. Further 
investigations are needed to identify the exact mechanism of action of 
DIOS.   
Thereafter, the effect of DIOS on OTA-exposed cells was tested. Based on 
our previous observations, low OTA concentrations (5-15 µM) cause major 
changes on ATP levels at least after 24-hour treatment. On the other hand, 
DIOS seems to be effective under shorter incubation times (6-12 hours). 
Therefore MDCK cells were treated with 15 µM OTA and after 12-hour 
incubation the system was supplemented/co-treated with 0-15 µM DIOS 
(without the replacement of the previous medium) and cells were incubated 
for further 12 hours. Each applied DIOS concentrations (5, 10 and 15 µM) 
resulted in the significant elevation of ATP/protein ratio in OTA-co-treated 
cells. The impact is so effective that 15 µM DIOS restores completely the 
intracellular ATP levels. ROS/protein levels were also quantified, DIOS 
caused significant but not dramatic decrease of ROS/protein ratios in co-
treated (both OTA and DIOS) cells compared to the simply OTA-exposed 
cells. Unfortunately, the negative effect of OTA on cell cycle cannot be 
alleviated with DIOS or with antioxidants.  
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5. Conclusions, new findings 
 We verified the suitability of the previously described fluorescence 
polarization-based method for quantification of OTA-HSA interaction 
as well. 
 
 We determined the complex stabilities of OTA-albumin complexes 
applying human, bovine and rat serum albumin under the same 
conditions. 
 
 We established that furosemide, glipizide and simvastatin were able 
while phenobarbital and acetylsalicylic acid (contrary to the earlier 
assumptions) were unable to displace OTA from HSA. 
 
 We described and chemically and quantitatively characterized the 
competitive interaction between flavonoid aglycones and OTA for 
binding to HSA. 
 
 We identified and characterized the interactions of OTA with alkali 
earth ions, alkaline earth ions and zinc ions. We developed a novel 
HPLC-FLD method based on the principle of the higher fluorescence 
of OTA
2-
-Mg
2+ 
complex. 
 
 We described at the first time the OTA2--QABCD interaction which 
complex is more stable than the previously examined OTA-CD 
complexes. Furthermore, QABCD shows strong preference towards the 
dianionic form of OTA. 
 
 We demonstrated that the main toxic mechanism of OTA in MDCK 
cells is the G2 phase cell cycle arrest. Antioxidants cannot alleviate this 
effect. 
 
 We demonstrated the positive effect of diosmetin on cellular ATP 
levels and that diosmetin is able to restore ATP levels in OTA-exposed 
MDCK cells. 
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